MedPath

Chung Mei Biopharma Co., Ltd

Ownership
Private
Employees
-
Market Cap
-
Website

Safety and Efficacy of DCB-BO1301 in Advanced Melanoma

Phase 1
Not yet recruiting
Conditions
Advanced Melanoma
Interventions
First Posted Date
2016-12-16
Last Posted Date
2022-03-18
Lead Sponsor
Chung Mei Biopharma Co., Ltd
Target Recruit Count
33
Registration Number
NCT02994498
© Copyright 2025. All Rights Reserved by MedPath